244 related articles for article (PubMed ID: 28446295)
21. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
23. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
24. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
Chen W; Li S
Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
[TBL] [Abstract][Full Text] [Related]
26. Novel circulating microRNAs expression profile in colon cancer: a pilot study.
Wang YN; Chen ZH; Chen WC
Eur J Med Res; 2017 Nov; 22(1):51. PubMed ID: 29187262
[TBL] [Abstract][Full Text] [Related]
27. Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3.
Ullah A; Rehman IU; Ommer K; Ahmed N; Odenthal M; Yu X; Ahmad J; Nadeem T; Ali Q; Ahmad B
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239415
[TBL] [Abstract][Full Text] [Related]
28. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
29. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
Hao M; Zang M; Zhao L; Deng S; Xu Y; Qi F; An G; Qin Y; Sui W; Li F; Yang W; Li Z; Yi S; Zou D; Zhan F; Qiu L
Oncotarget; 2016 Apr; 7(15):19589-600. PubMed ID: 26995755
[TBL] [Abstract][Full Text] [Related]
30. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.
Mirzaei HR; Sahebkar A; Mohammadi M; Yari R; Salehi H; Jafari MH; Namdar A; Khabazian E; Jaafari MR; Mirzaei H
Curr Pharm Des; 2016; 22(34):5257-5269. PubMed ID: 26935703
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers.
Jamali L; Tofigh R; Tutunchi S; Panahi G; Borhani F; Akhavan S; Nourmohammadi P; Ghaderian SMH; Rasouli M; Mirzaei H
J Cell Physiol; 2018 Nov; 233(11):8538-8550. PubMed ID: 29923196
[TBL] [Abstract][Full Text] [Related]
32. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.
Shen X; Ye Y; Qi J; Shi W; Wu X; Ni H; Cong H; Ju S
Clin Chem Lab Med; 2017 May; 55(5):748-754. PubMed ID: 27155004
[TBL] [Abstract][Full Text] [Related]
34. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
Ramzy I; Hasaballah M; Marzaban R; Shaker O; Soliman ZA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):508-15. PubMed ID: 25736690
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
38. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs in urine are not biomarkers of multiple myeloma.
Sedlaříková L; Bešše L; Novosadová S; Kubaczková V; Radová L; Staník M; Krejčí M; Hájek R; Ševčíková S
J Negat Results Biomed; 2015 Sep; 14():16. PubMed ID: 26399230
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma.
Zhao G; Jing X; Li Z; Wu X; Gao Z; Ma R
Hematology; 2022 Dec; 27(1):778-784. PubMed ID: 35793786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
